HAE FY 2024 Earnings Report — Haemonetics Corporation Revenue & Financial Results | Market Cap Arena

Haemonetics CorporationHAE

FY 2024 Earnings

Reported May 20, 2024

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2024	Prior Q	FY 2023	QoQ Change	YoY Change
Revenue	$1.3B	—	$1.2B	—	12.0%
Op. Income	$165M	—	$156M	—	5.7%
Gross Margin	54.4%	—	53.3%	—	1.1pp
Net Margin	9.0%	—	9.9%	—	-0.9pp
EPS (Diluted)	$2.29	—	$2.24	—	2.2%
Free Cash Flow	$115M	—	$163M	—	-29.1%

Revenue Flow

Item	Amount
REVENUE	$1.3B
Cost of Revenue	$597M
GROSS PROFIT	$712M
R&D Expenses	$63M
Selling & Marketing	$7M
General & Administrative	$414M
SG&A Expenses	$421M
Other Expenses	$63M
Operating Expenses	$547M
Cost & Expenses	$1.1B
OPERATING INCOME	$165M
Interest Income	$0
Interest Expense	$13M
Other Income/Expenses	-$13M
INCOME BEFORE TAX	$152M
Income Tax Expense	$34M
Net Income from Continuing Ops	$118M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$118M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$118M
D&A	$89M
EBIT	$207M
EBITDA	$295M
EPS	$2
EPS Diluted	$2

Income Statement

Item	Amount
REVENUE	$1.3B
Cost of Revenue	$597M
GROSS PROFIT	$712M
R&D Expenses	$63M
Selling & Marketing	$7M
General & Administrative	$414M
SG&A Expenses	$421M
Other Expenses	$63M
Operating Expenses	$547M
Cost & Expenses	$1.1B
OPERATING INCOME	$165M
Interest Income	$0
Interest Expense	$13M
Other Income/Expenses	-$13M
INCOME BEFORE TAX	$152M
Income Tax Expense	$34M
Net Income from Continuing Ops	$118M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$118M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$118M
D&A	$89M
EBIT	$207M
EBITDA	$295M
EPS	$2
EPS Diluted	$2

Cash Flow Statement

Item	Amount
Net Income	$118M
Depreciation & Amortization	$97M
Stock-Based Compensation	$28M
Deferred Income Tax	-$11M
Other Non-Cash Items	$24M
Change in Working Capital	-$75M
OPERATING CASH FLOW	$182M
Capital Expenditure	-$66M
Acquisitions (Net)	-$241M
Purchases of Investments	-$16M
Sales/Maturities of Investments	$0
Other Investing Activities	$0
NET CASH FROM INVESTING	-$322M
Net Debt Issuance	$38M
Common Stock Repurchased	$0
Common Dividends Paid	$0
Other Financing Activities	-$7M
NET CASH FROM FINANCING	$38M
FREE CASH FLOW	$115M
Net Change in Cash	-$106M

Balance Sheet

Item	Amount
Cash & Equivalents	$179M
Short-Term Investments	$0
Net Receivables	$207M
Inventory	$317M
Other Current Assets	$66M
TOTAL CURRENT ASSETS	$769M
PP&E (Net)	$367M
Goodwill	$565M
Intangible Assets	$406M
Long-Term Investments	$0
Tax Assets	$8M
Other Non-Current Assets	$81M
TOTAL NON-CURRENT ASSETS	$1.4B
TOTAL ASSETS	$2.2B
Account Payables	$73M
Short-Term Debt	$10M
Deferred Revenue	$31M
Other Current Liabilities	$105M
TOTAL CURRENT LIABILITIES	$300M
Long-Term Debt	$798M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$63M
Other Non-Current Liabilities	$75M
TOTAL NON-CURRENT LIABILITIES	$935M
TOTAL LIABILITIES	$1.2B
Common Stock	$508.0K
Additional Paid-In Capital	$635M
Retained Earnings	$360M
Treasury Stock	$0
Accum. Other Comp. Income	-$36M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$960M
Minority Interest	$0
TOTAL EQUITY	$960M
TOTAL LIABILITIES & EQUITY	$2.2B
Total Debt	$808M
Net Debt	$629M